Bifiform, 30 pcs.
€19.15 €15.95
Enterococcus faecium and Bifidobacterium longum strains included in the drug are natural symbiotic bacteria that inhabit the gastrointestinal tract. The drug has a normalizing effect on the quantitative and qualitative composition of the intestinal microflora.
The action is conditioned by direct direct effect of ingredients of the preparation (high antagonistic activity in respect of pathogenic and conditionally pathogenic microorganisms) and indirect – stimulation of local intestinal immunity (activation of immunoglobulin A synthesis, induction of endogenous interferon synthesis).
Bifidobacterium longum has high survival rate in human intestine and high growth rate. Inclusion of Enterococcus faecium apathogenic enterococcus that normally colonizes small intestine allows to have a positive effect on condition and digestive functions of not only large but also small intestine, especially in case of fermentative dyspepsia and flatulence phenomena.
Indications
Active ingredient
Composition
How to take, the dosage
Special Instructions
The maximum daily dose should not be exceeded.
Synopsis
Contraindications
Weight | 0.025 kg |
---|---|
Manufacturer | Pfizer Consumer Manufacturing Italy S.R.L., Italy |
Medication form | enteric capsules |
Brand | Pfizer Consumer Manufacturing Italy S.R.L. |
Related products
Buy Bifiform, 30 pcs. with delivery to USA, UK, Europe and over 120 other countries.